Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5396747, 8 pages
http://dx.doi.org/10.1155/2016/5396747
Research Article

A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma

Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China

Received 23 February 2016; Accepted 29 March 2016

Academic Editor: Czar L. Gaston

Copyright © 2016 Peng-Cheng Chen and Ji-Feng Feng. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Lin, Y. Totsuka, Y. He et al., “Epidemiology of esophageal cancer in Japan and China,” Journal of Epidemiology, vol. 23, no. 4, pp. 233–242, 2013. View at Publisher · View at Google Scholar
  3. K. K. Keditsu, S. Jiwnani, G. Karimundackal, and C. S. Pramesh, “Multimodality management of esophageal cancer,” Indian Journal of Surgical Oncology, vol. 4, no. 2, pp. 96–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” The Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Nakamura, A. Matsumine, K. Asanuma, T. Matsubara, and A. Sudo, “The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma,” Tumor Biology, vol. 36, no. 10, pp. 7515–7520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Jiang, J.-Y. Deng, Y. Liu, B. Ke, H.-G. Liu, and H. Liang, “The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer,” Biomarkers, vol. 19, no. 6, pp. 444–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Nozoe, T. Iguchi, E. Adachi, A. Matsukuma, and T. Ezaki, “Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer,” Surgery Today, vol. 41, no. 4, pp. 510–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Nakamura, A. Matsumine, T. Matsubara, K. Asanuma, A. Uchida, and A. Sudo, “The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma,” Journal of Surgical Oncology, vol. 108, no. 7, pp. 481–485, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Nakamura, R. J. Grimer, C. L. Gaston, M. Watanuki, A. Sudo, and L. Jeys, “The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone,” Bone & Joint Journal B, vol. 95, no. 3, pp. 411–418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Nakamura, R. Grimer, C. Gaston et al., “The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma,” European Journal of Cancer, vol. 49, no. 2, pp. 377–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shimada, Y. Nabeya, S.-I. Okazumi et al., “Elevation of pre-operative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma,” Journal of Surgical Oncology, vol. 83, no. 4, pp. 248–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Rashid, N. Waraich, I. Bhatti et al., “A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection,” World Journal of Surgical Oncology, vol. 8, article 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Sato, Y. Tsubosa, and T. Kawano, “Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer,” World Journal of Surgery, vol. 36, no. 3, pp. 617–622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Z. Sharaiha, K. J. Halazun, F. Mirza et al., “Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer,” Annals of Surgical Oncology, vol. 18, no. 12, pp. 3362–3369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Dutta, A. B. C. Crumley, G. M. Fullarton, P. G. Horgan, and D. C. McMillan, “Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer,” World Journal of Surgery, vol. 35, no. 8, pp. 1861–1866, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-F. Feng, Y. Huang, and Q.-X. Chen, “Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma,” World Journal of Surgical Oncology, vol. 12, article 58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. W. Rice, V. W. Rusch, H. Ishwaran, and E. H. Blackstone, “Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals,” Cancer, vol. 116, no. 16, pp. 3763–3773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. E. Diehl, G. K. Haines III, J. A. Radosevich, and L. A. Potempa, “Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue,” The American Journal of the Medical Sciences, vol. 319, no. 2, pp. 79–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Liu, Y. Huang, X. Yang, and J. F. Feng, “A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophagealsquamous cell carcinoma,” American Journal of Cancer Research, vol. 5, pp. 2180–2189, 2015. View at Google Scholar
  21. B. P. L. Wijnhoven, K. T. C. Tran, A. Esterman, D. I. Watson, and H. W. Tilanus, “An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus,” Annals of Surgery, vol. 245, no. 5, pp. 717–725, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. G. Peyre, J. A. Hagen, S. R. DeMeester et al., “The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection,” Annals of Surgery, vol. 248, no. 4, pp. 549–556, 2008. View at Publisher · View at Google Scholar · View at Scopus